A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks
Diabetes Care
.
2018 Jun;41(6):1121-1124.
doi: 10.2337/dci18-0018.
Authors
Matthew C Riddle
1
,
Hertzel C Gerstein
2
,
Rury R Holman
3
,
Silvio E Inzucchi
4
,
Bernard Zinman
5
,
Sophia Zoungas
6
,
William T Cefalu
7
Affiliations
1
Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR riddlem@ohsu.edu.
2
McMaster University and Hamilton Health Sciences Center, Population Health Research Institute, Hamilton, Ontario, Canada.
3
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
4
Section of Endocrinology, Yale School of Medicine, New Haven, CT.
5
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
6
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
7
American Diabetes Association, Arlington, VA.
PMID:
29784695
DOI:
10.2337/dci18-0018
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't